Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

about

DNA Repair Pathway Alterations in Bladder Cancer.

P2860

Q33607945-9B3BBE71-4D79-4EA3-8980-F968FF1A80FC

P2860

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

Item

http://www.wikidata.org/entity/Q39790653

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical Evaluation of Cisplat ...... therapy for Urothelial Cancer.

@en

Clinical Evaluation of Cisplat ...... therapy for Urothelial Cancer.

@nl

type

Item

label

Clinical Evaluation of Cisplat ...... therapy for Urothelial Cancer.

@en

Clinical Evaluation of Cisplat ...... therapy for Urothelial Cancer.

@nl

prefLabel

Clinical Evaluation of Cisplat ...... therapy for Urothelial Cancer.

@en

Clinical Evaluation of Cisplat ...... therapy for Urothelial Cancer.

@nl

P1476

Clinical Evaluation of Cisplat ...... therapy for Urothelial Cancer.

@en

P2093

Christopher Manschreck

http://www.w3.org/2001/XMLSchema#string

Cory Ganshert

http://www.w3.org/2001/XMLSchema#string

Dean F Bajorin

http://www.w3.org/2001/XMLSchema#string

Elizabeth R Plimack

http://www.w3.org/2001/XMLSchema#string

Gary D Steinberg

http://www.w3.org/2001/XMLSchema#string

Hongyuan Cao

http://www.w3.org/2001/XMLSchema#string

Ilana R Garcia-Grossman

http://www.w3.org/2001/XMLSchema#string

Irina Ostrovnaya

http://www.w3.org/2001/XMLSchema#string

Kelly L Stratton

http://www.w3.org/2001/XMLSchema#string

Norm D Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Germline pharmacogenomics in oncology: decoding the patient for targeting therapy

The International HapMap Project

Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy

A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity

Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

P304

511-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLGC.2016.03.006

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth Offit

Joseph Vijai

P577

2016-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27150640

http://www.w3.org/2001/XMLSchema#string

P932

5018246

http://www.w3.org/2001/XMLSchema#string

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

about

P2860

P2860

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932